Scientists reported updated results on the number and characteristics of breast cancer, as well as the frequency of abnormal mammograms, in the estrogen and progestin (E+P) arm of the Women’s Health Initiative Study (WHI). When comparing patients who developed invasive breast cancer to those on placebo, tumors in the E+P group were larger (mean 1.7 […]